Duchenne Muscular Dystrophy

A patient in Akashi's suspended Duchenne MD trial dies
Fierce Biotech
Sat, 02/6/16 - 12:26 pm
Akashi Therapeutics
clinical trials
Duchenne Muscular Dystrophy
HT-100
Why the FDA shouldn’t bow to parental pressure over Duchenne drug
Stat
Tue, 01/26/16 - 09:17 pm
FDA
Duchenne Muscular Dystrophy
drug approvals
Biomarin
Sarepta Therapeutics
Duchenne drug by Cambridge's Catabasis looks safe in early trial
Bizjournals.com
Mon, 01/25/16 - 09:48 am
Duchenne Muscular Dystrophy
Catabasis
Forbes: There Is 'A Bit' Of Hope For Sarepta Therapeutics
Yahoo/Benzinga
Fri, 01/22/16 - 09:35 pm
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
FDA Postpones Advisory Committee Meeting to Review Eteplirsen Due to Severe Weather Storm in the Washington D.C. Area
Yahoo
Thu, 01/21/16 - 09:38 am
FDA
advisory panels
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics
Four big problems with the FDA’s analysis of Sarepta’s Duchenne drug data
Bizjournals.com
Wed, 01/20/16 - 09:31 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
​Duchenne mom: FDA is ‘looking for reasons to deny’ Sarepta’s drug
Bizjournals.com
Fri, 01/15/16 - 02:28 pm
FDA
Sarepta Therapeutics
eteplirsen
Duchenne Muscular Dystrophy
BioMarin Fails to Win Approval for Drug to Treat Deadly Duchenne
Bloomberg
Thu, 01/14/16 - 10:07 am
Biomarin
FDA
Duchenne Muscular Dystrophy
Kyndrisa
drisapersen
Patient-funded biotech in $100 mln funding deal for DMD drug
Yahoo/Reuters
Sat, 01/9/16 - 10:41 am
Duchenne Muscular Dystrophy
Akashi Therapeutics
BioMarin Announces That FDA Has Advised it Will Not Take Action on the Kyndrisa™ (drisapersen) New Drug Application by the PDUFA Date
Yahoo
Fri, 12/18/15 - 09:07 am
Biomarin
FDA
drisapersen
Kyndrisa
Duchenne Muscular Dystrophy
FDA Committee Raises Concerns about Kyndrisa’s Efficacy, Safety
Yahoo/Market Realist
Fri, 12/11/15 - 10:27 pm
FDA
Kyndrisa
Duchenne Muscular Dystrophy
Biomarin
drisapersen
Sarepta Therapeutics' Eteplirsen Likely To Get A Conditional Approval By FDA
Seeking Alpha
Tue, 12/1/15 - 08:54 pm
FDA
Duchenne Muscular Dystrophy
Sarepta Therapeutics
eteplirsen
DMD Drugs: An Existential Threat To The FDA?
Forbes
Mon, 11/30/15 - 10:46 am
FDA
Duchenne Muscular Dystrophy
BioMarin: So You’re Saying There’s a Chance?
Barron's
Wed, 11/25/15 - 11:31 am
Biomarin
Duchenne Muscular Dystrophy
drisapersen
Kyndrisa
FDA
BioMarin Duchenne drug appears destined for failure after brutal FDA meeting
BioPharma Dive
Wed, 11/25/15 - 10:53 am
Biomarin
Duchenne Muscular Dystrophy
FDA
advisory panels
drisapersen
​The first drug for Duchenne will be reviewed at the FDA today: Why it matters
Bizjournals.com
Tue, 11/24/15 - 09:51 am
FDA
Biomarin
advisory panels
Duchenne Muscular Dystrophy
Kyndrisa
drisapersen
BioMarin FDA Panel Live Blog
TheStreet.com
Tue, 11/24/15 - 09:06 am
Biomarin
FDA
advisory panels
Duchenne Muscular Dystrophy
drisapersen
Duchenne moms say FDA documents ‘widen the divide’ between drugs by BioMarin, Sarepta
Bizjournals.com
Fri, 11/20/15 - 06:19 pm
Duchenne Muscular Dystrophy
FDA
eterplirsen
drisapersen
Biomarin
Sarepta Therapeutics
FDA staff unveils strongly critical review of BioMarin Duchenne drug ahead of crucial meeting
BioPharma Dive
Fri, 11/20/15 - 11:11 am
FDA
Biomarin
Duchenne Muscular Dystrophy
drisapersen
Experts say Sarepta has a clear edge over BioMarin in Duchenne drug battle
Bizjournals.com
Thu, 11/5/15 - 12:47 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
eteplirsen
drisapersen

Pages